Skip to main content
SpringerLink
Log in

Haben ACE-Hemmer und Calciumantagonisten die Therapie der Hypertonie verbessert?

ACE-inhibitors and calcium antagonists: an alternative for treatment of hypertension?

  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Angiotensin converting enzyme (ACE)-inhibitors combined with diuretics and, if necessary, with calcium antagonists can be used with good success for the treatment of otherwise resistant hypertension.

Calcium antagonists are an alternative for physically active hypertensive patients who complain of muscular fatigue during treatment with beta-receptor-blocking agents. The calcium antagonist nifedipine has made the treatment of hypertensive emergencies much easier than with the use of clonidine and particularly sodium nitroprusside. In order to determine the place of ACE-inhibitors and of calcium antagonists in the treatment of hypertension-particularly in comparison with beta-blockers and diuretics- controlled long-term studies on the prognosis of patients with mild to moderate hypertension and on the incidence of side effects would be required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Atkinson AB, Brown JJ, Lever AF, Robertson JIS (1980) Comined treatment of severe intractable hypertension with captopril and diuretic. Lancet II:105–107

    Google Scholar 

  • Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Brit Med J 293:471–474

    Google Scholar 

  • Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins D, Klerman GL, Williams GH (1986) The effects of antihypertensive therapy on the quality of life. New Engl J Med 314:1657–1664

    Google Scholar 

  • Fellenius E (1983) Muscle fatigue and beta-blockers-a review. Int J Sports Med 4:1–8

    Google Scholar 

  • Hommel E, Parving HH, Mathiesen E, Edsberg B, Damkjar Nielsen M, Giese J (1986) Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Brit Med J 293:467–470

    Google Scholar 

  • Lange Andersen K, Piatkowski W, Green KA, Ottman W (1985) Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adrenoreceptor blocking drug and a calcium antagonist. Int Arch Occup Environ Health 56:41–47

    Google Scholar 

  • Magometschnigg D (1982) Zur Therapie bei hypertonen Krisen. Dtsch Med Wschr 107:1423–1428

    Google Scholar 

  • Management Committee of the Australian Therapeutic Trial in Mild Hypertension (1980) The Australian therapeutic trial in mild hypertension. Lancet I:1261–1267

    Google Scholar 

  • Medical Research Council Working Party on Mild to Moderate Hypertension (1981) Adverse reaction to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet II:539–543

    Google Scholar 

  • Medical Research Council Working Party on Mild to Moderate Hypertension (1985) MRC trial of treatment of mild hypertension: principal results. Brit Med J 291:97–104

    Google Scholar 

  • Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Brit Med J 285:685–688

    Google Scholar 

  • Mooy J, van Baak M, Böhm R, Does R, Petri H, van Kemenade J, Rahn KH (1987) The effects of verapamil und propranolol on exercise tolerance in hypertensive patients. Clin Pharmacol Ther 41:490–495

    Google Scholar 

  • Rahn KH (1980) The use of vasodilating agents in the treatment of a hypertensive crisis. Progr Pharmacol 3/4:115–119

    Google Scholar 

  • Rahn KH (1987) Medikamentöse Therapie der arteriellen Hypertonie. Verh Deut Ges Inn Med 93:241–246

    Google Scholar 

  • Raine AEG, Ledingham JGG (1982) Clinical experience with captopril in the treatment of severe drug-resistant hypertension. Amer J Cardiol 49:1475–1479

    Google Scholar 

  • Van Baak M, Jennen W, Verstappen FTJ (1985) Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol. Eur J Clin Pharmacol 8:143–148

    Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents (1977) Propranolol in the treatment of essential hypertension. JAMA 237:2303–2310

    Google Scholar 

  • White WB, Viadero JJ, Lane TJ, Podesla S (1986) Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther 39:43–48

    Google Scholar 

  • Wilcox RG, Bennett T, Macdonald JA, Herbert M, Skene AM (1984) The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men. Brit J Clin Pharmacol 17:273–281

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Poliklinik der Westfälischen Wilhelms-Universität Münster, Germany

    K. H. Rahn

Authors
  1. K. H. Rahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahn, K.H. Haben ACE-Hemmer und Calciumantagonisten die Therapie der Hypertonie verbessert?. Klin Wochenschr 66, 920–923 (1988). https://doi.org/10.1007/BF01728955

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01728955

Key words

Search

Navigation